Management and board
Executive Group Management Team
The Scantox Executive Group Management (EMGT) brings extensive experience from the CRO industry, pharma, academia and regulatory compliance. Our key focus is bringing the best people on board and develop Scantox to service our clients in the best possible way.
Scantox is owned by the Nordic based investment company Impilo. Impilo is focused solely on investments in Nordic companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Their starting point is that their portfolio companies must contribute to a positive and sustainable development of the communities and markets in which they operate in order to remain successful in the long term. Impilo invests in people’s opportunities to enjoy healthier lives in the future.
Board of Directors
Members of the Scantox Board of Directors are experts bringing strong knowledge and solid experience within the fields of science, leadership, entrepreneurship and private equity.